BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01062152-completion@plaintrial.com
DTSTAMP:20261028T055854Z
DTSTART;VALUE=DATE:201303
SUMMARY:Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients W
 ith Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome 
 (MDS) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01062152
URL:https://plaintrial.com/trial/NCT01062152
END:VEVENT
END:VCALENDAR
